Stay updated with breaking news from Spharm Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
For the first time in nearly 15 years, the U.S. Patent and Trademark Office (USPTO) has issued "Updated Guidance for Making a Proper Determination of Obviousness" under the U.S.
For the first time in nearly 15 years, the U.S. Patent and Trademark Office (USPTO) has issued “Updated Guidance for Making a Proper Determination of Obviousness” under the U.S. Supreme...
One of the main risks that a company faces after a data breach is a potential lawsuit. Plaintiffs often will allege creative statutory and common law theories of harm after they learn that their personal information...
(December 27, 2023) Natera Inc. succeeded in obtaining a preliminary injunction against NeoGenomics Laboratories, Inc.’s medical assay test. Natera’s ongoing federal lawsuit alleges...
The United States Court of Appeals for the Federal Circuit recently delivered a precedential opinion in Baxalta v. Genentech, affirming the invalidity of patent claims directed to a genus of antibodies...